Literature DB >> 21692660

Deep brain stimulation for psychiatric disorders.

Paul E Holtzheimer1, Helen S Mayberg.   

Abstract

Medications, psychotherapy, and other treatments are effective for many patients with psychiatric disorders. However, with currently available interventions, a substantial number of patients experience incomplete resolution of symptoms, and relapse rates are high. In the search for better treatments, increasing interest has focused on focal neuromodulation. This focus has been driven by improved neuroanatomical models of mood, thought, and behavior regulation, as well as by more advanced strategies for directly and focally altering neural activity. Deep brain stimulation (DBS) is one of the most invasive focal neuromodulation techniques available; data have supported its safety and efficacy in a number of movement disorders. Investigators have produced preliminary data on the safety and efficacy of DBS for several psychiatric disorders, as well. In this review, we describe the development and justification for testing DBS for various psychiatric disorders, carefully consider the available clinical data, and briefly discuss potential mechanisms of action.

Entities:  

Mesh:

Year:  2011        PMID: 21692660      PMCID: PMC4413475          DOI: 10.1146/annurev-neuro-061010-113638

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  124 in total

1.  Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat.

Authors:  David A Slattery; Inga D Neumann; John F Cryan
Journal:  J Psychopharmacol       Date:  2010-06-08       Impact factor: 4.153

2.  ELECTRICAL SELF-STIMULATION OF THE BRAIN IN MAN.

Authors:  R G HEATH
Journal:  Am J Psychiatry       Date:  1963-12       Impact factor: 18.112

3.  Long-term outcome of neurosurgery for the treatment of resistant depression.

Authors:  Perminder S Sachdev; Jagdeep Sachdev
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

4.  Lower stimulation frequency can enhance tolerability and efficacy of pallidal deep brain stimulation for dystonia.

Authors:  Ron L Alterman; Jay L Shils; Joan Miravite; Michele Tagliati
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

5.  The Origin and Nature of the Hypoglycemic Therapy of the Psychoses.

Authors:  M Sakel
Journal:  Bull N Y Acad Med       Date:  1937-03

6.  Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months.

Authors:  Heather E McNeely; Helen S Mayberg; Andres M Lozano; Sidney H Kennedy
Journal:  J Nerv Ment Dis       Date:  2008-05       Impact factor: 2.254

7.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

8.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

Review 9.  Stereotactic cingulotomy.

Authors:  G Rees Cosgrove; Scott L Rauch
Journal:  Neurosurg Clin N Am       Date:  2003-04       Impact factor: 2.509

10.  Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.

Authors:  Christopher G Goetz; Joanne Wuu; Michael P McDermott; Charles H Adler; Stanley Fahn; Curt R Freed; Robert A Hauser; Warren C Olanow; Ira Shoulson; P K Tandon; Sue Leurgans
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

View more
  83 in total

1.  The relative impact of microstimulation parameters on movement generation.

Authors:  Husam A Katnani; Neeraj J Gandhi
Journal:  J Neurophysiol       Date:  2012-04-25       Impact factor: 2.714

2.  Agency and intervention.

Authors:  Adina L Roskies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

3.  Metal Artifact Reduction in Head CT Performed for Patients with Deep Brain Stimulation Devices: Effectiveness of a Single-Energy Metal Artifact Reduction Algorithm.

Authors:  Y Nagayama; S Tanoue; S Oda; D Sakabe; T Emoto; M Kidoh; H Uetani; A Sasao; T Nakaura; O Ikeda; K Yamada; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

4.  From bed to bench side: Reverse translation to optimize neuromodulation for mood disorders.

Authors:  Peter H Rudebeck; Erin L Rich; Helen S Mayberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 5.  Dynamic network communication as a unifying neural basis for cognition, development, aging, and disease.

Authors:  Bradley Voytek; Robert T Knight
Journal:  Biol Psychiatry       Date:  2015-04-28       Impact factor: 13.382

6.  Design and in vivo evaluation of more efficient and selective deep brain stimulation electrodes.

Authors:  Bryan Howell; Brian Huynh; Warren M Grill
Journal:  J Neural Eng       Date:  2015-07-14       Impact factor: 5.379

7.  Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?

Authors:  Helen H Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-12       Impact factor: 11.205

Review 8.  Reward Circuitry in Addiction.

Authors:  Sarah Cooper; A J Robison; Michelle S Mazei-Robison
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

9.  A wideband dual-antenna receiver for wireless recording from animals behaving in large arenas.

Authors:  Seung Bae Lee; Ming Yin; Joseph R Manns; Maysam Ghovanloo
Journal:  IEEE Trans Biomed Eng       Date:  2013-02-15       Impact factor: 4.538

10.  Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study.

Authors:  Rajamannar Ramasubbu; Susan Anderson; Angela Haffenden; Swati Chavda; Zelma H T Kiss
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.